Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Regulatory information - eSubmission Gateway or web client mandatory for all eCTD submissions through the centralised procedure from 1 March 2014 7 Februar 2014NewsCorporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 February 2014 7 Februar 2014NewsHumanPharmacovigilance Committee for orphan medicines – overview of 2013 and looking ahead 3 Februar 2014NewsHumanRare diseases Regulatory information - EMA announces next steps for the maintenance of information on authorised medicines by marketing-authorisation holders 31 Januar 2014NewsCorporate Who are the originators of innovative medicines in the EU? 31 Januar 2014NewsCorporateInnovation EMA releases guidance on the use of pharmacogenomics to improve safety monitoring of medicines 30 Januar 2014NewsHuman European Medicines Agency publishes minutes of CHMP, CVMP and CAT meetings for the first time 28 Januar 2014NewsCorporateAdvanced therapiesMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 January 2014 24 Januar 2014NewsHuman Review of emergency contraceptives started 24 Januar 2014Press releaseHuman EMA recommends 81 medicines for marketing authorisation in 2013 20 Januar 2014NewsCorporate 1 … 207 208 209 210 211 Page 211 of 384 212 213 214 215 … 384
Regulatory information - eSubmission Gateway or web client mandatory for all eCTD submissions through the centralised procedure from 1 March 2014 7 Februar 2014NewsCorporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 February 2014 7 Februar 2014NewsHumanPharmacovigilance
Committee for orphan medicines – overview of 2013 and looking ahead 3 Februar 2014NewsHumanRare diseases
Regulatory information - EMA announces next steps for the maintenance of information on authorised medicines by marketing-authorisation holders 31 Januar 2014NewsCorporate
EMA releases guidance on the use of pharmacogenomics to improve safety monitoring of medicines 30 Januar 2014NewsHuman
European Medicines Agency publishes minutes of CHMP, CVMP and CAT meetings for the first time 28 Januar 2014NewsCorporateAdvanced therapiesMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 January 2014 24 Januar 2014NewsHuman